Pyrazinamide EP Impurity A

Enhanced Bactericidal Effects of Pyrazinamide Toward Mycobacterium smegmatis and Mycobacterium tuberculosis upon Conjugation to a {Au(I)-triphenylphosphine}+ Moiety
Jenny Stenger-Smith, Mireille Kamariza, Indranil Chakraborty, Ramatoulaye Ouattara, Carolyn R. Bertozzi, and Pradip K. Mascharak
ACS Omega 2020, 5, 12, 6826–6833
 
Different spectrophotometric and TLC-densitometric methods for determination of pyrazinamide in presence of its impurity
Neven MagdyHabib, Nourudin WagihAli, Nada Sayed Abdelwhab, Maha Mohamed Abdelrahman
Bulletin of Faculty of Pharmacy, Cairo University Volume 55, Issue 1, June 2017, Pages 185-194
 
Optimization of a Stability-Indicating HPLC Method for the Simultaneous Determination of Rifampicin, Isoniazid, and Pyrazinamide in a Fixed-Dose Combination using Artificial Neural Networks
B.D. Glass, S. Agatonovic-Kustrin, Y.-J. Chen, and M.H. Wisch
Journal of Chromatographic Science, Vol. 45, January 2007 Pages 38-44

Pyrazinamide EP Impurity A is chemically pyrazine-2-carboxylic acid. It is also known as Pyrazinamide USP Related Compound A. Pyrazinamide EP Impurity A is supplied with detailed characterization data compliant with regulatory guideline. Pyrazinamide EP Impurity A can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pyrazinamide.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.